“monitoring levels and keeping hypotoxicity. So we won't…” — Take Aurally at 13:06
“monitoring levels and keeping hypotoxicity. So we won't talk too much about them because there's some quite complex pharmacology going on, but that's why you're putting in the adjunct doses. I suppose at that point as well, if we've got a patient who's got quite stubborn asthma, they may have had hospital admissions…”
0:00
20:02